FDA Inspection 1037465 — Neogen Corporation

Neogen Corporation — FEI 3009631819

The FDA completed an inspection of Neogen Corporation on January 11, 2018 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 11, 2018
Fiscal Year
2018
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Lexington, KY (United States)

Citations

IDCFRDescription
145021 CFR 211.113(a)Procedures for non-sterile drug products
181021 CFR 211.160(a)Lab controls established, including changes
202721 CFR 211.192Investigations of discrepancies, failures
240121 CFR 211.194(a)(4)Complete Test Data